{"id":60086,"date":"2024-09-27T13:04:20","date_gmt":"2024-09-27T11:04:20","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\/"},"modified":"2024-09-27T13:04:20","modified_gmt":"2024-09-27T11:04:20","slug":"covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\/","title":{"rendered":"Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Visit Covalon at booth 523 to discover the latest in compassionate vascular access solutions<\/i>\n<\/p>\n<p>MISSISSAUGA, Ontario&#8211;(BUSINESS WIRE)&#8211;Covalon Technologies Ltd. (the &#8220;Company&#8221; or &#8220;Covalon&#8221;) (TSXV: COV; OTCQX: CVALF), is pleased to announce its participation in the 2024 Association for Vascular Access (\u201cAVA\u201d) Annual Scientific Meeting. The event will take place from September 28 to 30 in Colorado. Founded in 1985, AVA\u2019s multidisciplinary membership is dedicated to advancing research, providing education, and fostering collaboration to improve patient outcomes in vascular access. Covalon is proud to be a part of this esteemed community and to contribute to the development of evidence-based innovations.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20240927012827\/en\/2255582\/5\/VascularAccess_products_copy.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240927012827\/en\/2255582\/22\/VascularAccess_products_copy.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240927012827\/en\/2255582\/5\/VascularAccess_products_copy.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240927012827\/en\/2255582\/21\/VascularAccess_products_copy.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240927012827\/en\/1767588\/5\/Covalon_News_Release_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240927012827\/en\/1767588\/22\/Covalon_News_Release_Logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240927012827\/en\/1767588\/5\/Covalon_News_Release_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240927012827\/en\/1767588\/21\/Covalon_News_Release_Logo.jpg\"><\/a><\/p>\n<p>\n\u201c<!-- no quote -->Our participation in the AVA Annual Scientific Meeting highlights Covalon\u2019s commitment to enhancing patient comfort and supporting improved vascular access clinical care,\u201d said Brent Ashton, Chief Executive Officer, Covalon. \u201c<!-- no quote -->Our silicone-adhesive dressings help to reduce the challenges of cumbersome acrylic dressing removals, while our vascular access line guard helps to protect against gross contamination. Together, these products combine safety, compassion, and innovation to help improve clinical outcomes.&#8221;\n<\/p>\n<p>\nAt booth #523, Covalon will be showcasing its comprehensive range of compassionate vascular access solutions, including a new range of CovaClear<sup>\u00ae<\/sup> IV Vascular Access Dressings. Attendees are invited to learn more about how these innovative products are helping healthcare providers deliver exceptional care to patients around the world. Covalon representatives will be available to discuss the latest advancements in vascular access technology and answer any questions.\n<\/p>\n<p>\nCovalon\u2019s patented vascular access products include:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.covalon.com%2Fproducts%2Fvalguard&amp;esheet=54127889&amp;newsitemid=20240927012827&amp;lan=en-US&amp;anchor=VALGuard%26%23174%3B&amp;index=1&amp;md5=f7f6933e53741304bd73d9c07336a2cd\" rel=\"nofollow noopener\" shape=\"rect\">VALGuard<sup>\u00ae<\/sup><\/a> &#8211; a transparent line guard designed to protect IV line connections and hubs from external contaminants, including body fluids and other secretions.\n<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.covalon.com%2Fproducts%2Fsurgiclear&amp;esheet=54127889&amp;newsitemid=20240927012827&amp;lan=en-US&amp;anchor=SurgiClear%26%23174%3B&amp;index=2&amp;md5=1aee8431ab8fa081ed627d29ee948c03\" rel=\"nofollow noopener\" shape=\"rect\">SurgiClear<sup>\u00ae<\/sup><\/a> &#8211; a dual antimicrobial clear silicone adhesive dressing with Chlorhexidine and Silver used to cover and protect wound sites and wound closure devices.\n<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.covalon.com%2Fproducts%2Fiv-clear&amp;esheet=54127889&amp;newsitemid=20240927012827&amp;lan=en-US&amp;anchor=IV+Clear%26%23174%3B&amp;index=3&amp;md5=53512a4567a7503ab71151cde828b1d2\" rel=\"nofollow noopener\" shape=\"rect\">IV Clear<sup>\u00ae<\/sup><\/a> &#8211; a dual antimicrobial (Chlorhexidine and Silver) clear IV securement dressing that provides antimicrobial protection throughout the entire dressing surface area.\n<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcovalon.com%2Fproducts%2Fcovaclear-iv&amp;esheet=54127889&amp;newsitemid=20240927012827&amp;lan=en-US&amp;anchor=CovaClear%26%23174%3B+IV&amp;index=4&amp;md5=e4c5af960b7c2d36af79f9c8b3a8862d\" rel=\"nofollow noopener\" shape=\"rect\">CovaClear<sup>\u00ae<\/sup> IV<\/a> &#8211; a soft silicone adhesive clear IV dressing that helps protect insertion sites from external contaminants. Suitable for patients who either don\u2019t require, or cannot tolerate, antimicrobials<b>.<\/b>\n<\/li>\n<\/ul>\n<p>\n<b>Scheduling Appointments and Additional Information<\/b>\n<\/p>\n<p>\nTo book an appointment with a Covalon representative, please email Ron Hebert, SVP Growth, Covalon Technologies Ltd., at <a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;o&#58;&#x72;h&#101;&#x62;e&#114;&#x74;&#64;&#99;&#x6f;v&#97;&#x6c;o&#110;&#x2e;c&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#114;&#x68;e&#x62;&#x65;&#114;&#x74;&#64;&#x63;&#x6f;&#118;&#x61;l&#x6f;&#x6e;&#46;&#x63;o&#x6d;<\/a>.\n<\/p>\n<p>\n<b>Conference Details<\/b>\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nDates: September 28 \u2013 30 2024\n<\/li>\n<li>\nLocation: Gaylord Rockies Resort &amp; Convention Center, 6700 N Gaylord Rockies Blvd, Aurora, CO 80019, United States\n<\/li>\n<li>\nRegistration: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Favasm24.eventscribe.net&amp;esheet=54127889&amp;newsitemid=20240927012827&amp;lan=en-US&amp;anchor=https%3A%2F%2Favasm24.eventscribe.net&amp;index=5&amp;md5=e5a6e15fb17ff3c52c308ee3f67196cd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/avasm24.eventscribe.net<\/a>\n<\/li>\n<\/ul>\n<p>\nFor healthcare providers unable to attend the conference, Covalon encourages you to visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.covalon.com%2F&amp;esheet=54127889&amp;newsitemid=20240927012827&amp;lan=en-US&amp;anchor=www.covalon.com&amp;index=6&amp;md5=ac3820e8046418d62b968d1e1864fd65\" rel=\"nofollow noopener\" shape=\"rect\">www.covalon.com<\/a> or follow the company on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fcovalon-technologies-ltd&amp;esheet=54127889&amp;newsitemid=20240927012827&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=7&amp;md5=08202802a58f2afef2120e29c86b4354\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FCovalonTechnologies%2F&amp;esheet=54127889&amp;newsitemid=20240927012827&amp;lan=en-US&amp;anchor=Facebook&amp;index=8&amp;md5=3ac7741a3d9f316eb897cc59c4feb9e7\" rel=\"nofollow noopener\" shape=\"rect\">Facebook<\/a>, or <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fcovalon&amp;esheet=54127889&amp;newsitemid=20240927012827&amp;lan=en-US&amp;anchor=Instagram&amp;index=9&amp;md5=6687f306e6b4cfb3173049e79a7ead53\" rel=\"nofollow noopener\" shape=\"rect\">Instagram<\/a> to learn more about its solutions.\n<\/p>\n<p>\n<b>About Covalon<\/b>\n<\/p>\n<p>\nCovalon is a patient-driven medical device company, that provides innovative and cost-effective healthcare solutions for advanced wound care, infection control, and medical device coatings. Through a strong portfolio of patented technologies and solutions, we offer innovative, gentle and more compassionate options to aid patients on their healing journey. Our solutions are designed for patients and made for care providers. Covalon leverages its patented medical technology platforms and expertise in two ways: (i) by developing products that are sold under Covalon\u2019s name; and (ii) by developing and commercializing medical products for other medical companies under development and license contracts. The Company is listed on the TSX Venture Exchange, having the symbol COV and trades on the OTCQX Market under the symbol CVALF. To learn more about Covalon, visit our website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fna01.safelinks.protection.outlook.com%2F%3Furl%3Dhttp%253A%252F%252Fwww.covalon.com%26data%3D02%257C01%257C%257C6c73d1c9928a41c6e10508d639ab40b8%257C22d66b9c00bf4437bced9f9cdcdfd520%257C0%257C0%257C636759805008133179%26sdata%3DfeexzBWJvxwgFKmgXXX6M4A9%252FFYG%252FRPXav0FKy98cg8%253D%26reserved%3D0&amp;esheet=54127889&amp;newsitemid=20240927012827&amp;lan=en-US&amp;anchor=www.covalon.com&amp;index=10&amp;md5=4226e8d7a9655f67f3b12cad8a11e229\" rel=\"nofollow noopener\" shape=\"rect\">www.covalon.com<\/a>.\n<\/p>\n<p>\n<i>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.<\/i>\n<\/p>\n<p>\n<i>This news release may contain forward-looking statements which reflect the Company&#8217;s current expectations regarding future events. The forward-looking statements are often, but not always, identified by the use of words such as &#8220;seek&#8221;, &#8220;anticipate&#8221;, &#8220;plan, &#8220;estimate&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;<!-- no quote -->, or variations of such words and phrases or state that certain actions, events, or results \u201cmay\u201d, \u201ccould\u201d, \u201cwould\u201d, \u201cmight\u201d, \u201cwill\u201d or \u201cwill be taken\u201d, \u201coccur\u201d, or \u201cbe achieved\u201d. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts, but instead represent management\u2019s expectations, estimates, and projections regarding future events. Forward-looking statements involve risks and uncertainties, including, but not limited to, the factors described in greater detail in the \u201cRisks and Uncertainties\u201d section of our management\u2019s discussion and analysis of financial condition and results of operations for the year ended September 30, 2023, which is available on the Company\u2019s profile at <\/i><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sedarplus.ca&amp;esheet=54127889&amp;newsitemid=20240927012827&amp;lan=en-US&amp;anchor=www.sedarplus.ca&amp;index=11&amp;md5=0c195fba7cefd2069e9a4fd1914042d8\" rel=\"nofollow noopener\" shape=\"rect\"><i>www.sedarplus.ca<\/i><\/a><i>, any of which could cause results, performance, or achievements to differ materially from the results discussed or implied in the forward-looking statements. Investors should not place undue reliance on any forward-looking statements. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company assumes no obligation to update or alter any forward-looking statements, whether as a result of new information, further events, or otherwise, except as required by law.<\/i>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nTo learn more about Covalon, please contact:<\/p>\n<p>Investor Relations, Covalon Technologies Ltd.<br \/>\n<br \/>Email: <a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;&#x3a;i&#110;&#x76;e&#115;&#x74;&#x6f;r&#115;&#x40;c&#111;&#x76;&#x61;l&#111;&#x6e;&#x2e;&#99;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x69;n&#x76;e&#x73;&#116;&#x6f;&#114;s&#x40;c&#x6f;&#118;&#x61;&#108;&#x6f;&#110;&#46;&#x63;o&#x6d;<\/a><br \/>Website: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcovalon.com%2F&amp;esheet=54127889&amp;newsitemid=20240927012827&amp;lan=en-US&amp;anchor=https%3A%2F%2Fcovalon.com%2F&amp;index=12&amp;md5=6581f560a325661c93d7fb561af3f2db\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/covalon.com\/<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Visit Covalon at booth 523 to discover the latest in compassionate vascular access solutions MISSISSAUGA, Ontario&#8211;(BUSINESS WIRE)&#8211;Covalon Technologies Ltd. (the &#8220;Company&#8221; or &#8220;Covalon&#8221;) (TSXV: COV; OTCQX: CVALF), is pleased to announce its participation in the 2024 Association for Vascular Access (\u201cAVA\u201d) Annual Scientific Meeting. The event will take place from September 28 to 30 in &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-60086","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Visit Covalon at booth 523 to discover the latest in compassionate vascular access solutions MISSISSAUGA, Ontario&#8211;(BUSINESS WIRE)&#8211;Covalon Technologies Ltd. (the &#8220;Company&#8221; or &#8220;Covalon&#8221;) (TSXV: COV; OTCQX: CVALF), is pleased to announce its participation in the 2024 Association for Vascular Access (\u201cAVA\u201d) Annual Scientific Meeting. The event will take place from September 28 to 30 in ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-27T11:04:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240927012827\/en\/2255582\/22\/VascularAccess_products_copy.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting\",\"datePublished\":\"2024-09-27T11:04:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\\\/\"},\"wordCount\":862,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240927012827\\\/en\\\/2255582\\\/22\\\/VascularAccess_products_copy.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\\\/\",\"name\":\"Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240927012827\\\/en\\\/2255582\\\/22\\\/VascularAccess_products_copy.jpg\",\"datePublished\":\"2024-09-27T11:04:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240927012827\\\/en\\\/2255582\\\/22\\\/VascularAccess_products_copy.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240927012827\\\/en\\\/2255582\\\/22\\\/VascularAccess_products_copy.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting - Pharma Trend","og_description":"Visit Covalon at booth 523 to discover the latest in compassionate vascular access solutions MISSISSAUGA, Ontario&#8211;(BUSINESS WIRE)&#8211;Covalon Technologies Ltd. (the &#8220;Company&#8221; or &#8220;Covalon&#8221;) (TSXV: COV; OTCQX: CVALF), is pleased to announce its participation in the 2024 Association for Vascular Access (\u201cAVA\u201d) Annual Scientific Meeting. The event will take place from September 28 to 30 in ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\/","og_site_name":"Pharma Trend","article_published_time":"2024-09-27T11:04:20+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240927012827\/en\/2255582\/22\/VascularAccess_products_copy.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting","datePublished":"2024-09-27T11:04:20+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\/"},"wordCount":862,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240927012827\/en\/2255582\/22\/VascularAccess_products_copy.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\/","url":"https:\/\/pharma-trend.com\/en\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\/","name":"Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240927012827\/en\/2255582\/22\/VascularAccess_products_copy.jpg","datePublished":"2024-09-27T11:04:20+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240927012827\/en\/2255582\/22\/VascularAccess_products_copy.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240927012827\/en\/2255582\/22\/VascularAccess_products_copy.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/covalon-technologies-ltd-to-participate-in-the-2024-association-for-vascular-access-annual-scientific-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Covalon Technologies Ltd. to Participate in the 2024 Association for Vascular Access Annual Scientific Meeting"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60086","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=60086"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60086\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=60086"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=60086"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=60086"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}